EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -0.1046
March 31, 2026 -0.1043
December 31, 2025 -0.1287
September 30, 2025 -0.1202
June 30, 2025 -0.1325
March 31, 2025 -0.2109
December 31, 2024 -0.2729
September 30, 2024 -0.3221
June 30, 2024 -0.3595
March 31, 2024 -0.3465
December 31, 2023 -0.3247
September 30, 2023 -0.3418
June 30, 2023 -0.3658
March 31, 2023 -0.3454
December 31, 2022 -0.366
September 30, 2022 -0.3583
June 30, 2022 -0.3382
March 31, 2022 -0.359
December 31, 2021 -0.3544
September 30, 2021 -0.3322
June 30, 2021 -0.3126
March 31, 2021 -0.2863
December 31, 2020 -0.282
September 30, 2020 -0.3539
June 30, 2020 -0.3726
Date Value
March 31, 2020 -0.3848
December 31, 2019 -0.3571
September 30, 2019 -0.2498
June 30, 2019 -0.1999
March 31, 2019 -0.1633
December 31, 2018 -0.1541
September 30, 2018 -0.1615
June 30, 2018 -0.1744
March 31, 2018 -0.1749
December 31, 2017 -0.1752
September 30, 2017 -0.1786
June 30, 2017 -0.1553
March 31, 2017 -0.1651
December 31, 2016 -0.18
September 30, 2016 -0.18
June 30, 2016 0.01
March 31, 2016 0.00
December 31, 2015 0.00
September 30, 2015 -0.01
June 30, 2015 -0.24
March 31, 2015 -0.24
December 31, 2014 -0.24
September 30, 2014 -0.25
June 30, 2014 -0.25
March 31, 2014 -0.26

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Precigen, Inc. -1.100
Editas Medicine, Inc. -0.7446
Agenus, Inc. 2.651
Amgen, Inc. 16.10
Anika Therapeutics, Inc. -0.2741